News & Insights

Gunderson Dettmer co-sponsored the Longwood Healthcare Leaders Boston CEO Summit 2025, a two-day, invitation-only conference that convenes approximately 250 biopharma CEOs, R&D executives, government officials, life science investors, and leading academics for off-the-record discussions

Watch the Exclusive Premiere on What’s Next in Biotech with Gunderson Partner and Chair of Life Sciences Tim Ehrlich and Venrock Managing Partner Bryan Roberts

Gunderson Dettmer partner, Tim Ehrlich, to moderate a panel at the annual Genesis London Conference

Leading AI-enabled services partner for healthcare organizations, Third Way Health, announces its $15 million Series A financing by Health Velocity Capital.

Vir Biotechnology announces its underwritten public offering of 20,294,117 shares of common stock at $8.50 per share, including the exercise in full of the underwriters’ option to purchase additional shares.

Forbes recognizes 22 individuals across 13 Gunderson Dettmer clients in the 15th annual Forbes 30 Under 30 United States list, where clients were featured for their innovation, success, and leadership in categories including AI, Energy and Green Tech, Finance, Healthcare, and more

Richard Chang, Corporate Partner and Head of Gunderson Dettmer’s Beijing office, has once again been named to China Business Law Journal’s A-List as China’s 2025-26 Growth Drivers Elite International Lawyers.

LMG Life Sciences recognizes Gunderson Dettmer with Impact Deal of the Year and names Boston associate Joel Diamond the US Rising Star—Financial and Corporate in its 2025 Life Sciences Americas Awards

Gunderson Dettmer ranks as the most active law firm in the world for the second quarter in a row in PitchBook’s Q2 2025 Global League Tables, with 336 financings across the globe exceeding $25 billion in value